WHO DG Urges Nations To Join COVAX By Friday Deadline; U.K., China Testing Inhaled Vaccine Delivery; Vaccine Companies Must Scale Up Production, Serum Institute Executive Says

AP: U.K. tests if COVID-19 vaccines might work better inhaled (9/14).

CIDRAP News: Rising vaccine wariness in some nations doesn’t bode well for COVID vaccines (Van Beusekom, 9/11).

DW: Coronavirus vaccination: What are we actually waiting for? (Vergin, 9/11).

The Hill: China starts testing nasal spray coronavirus vaccine (Deese, 9/11).

Financial Times: Not enough Covid vaccine for all until 2024, says biggest producer (Findlay et al., 9/14).

New York Times: Vaccine Makers Keep Safety Details Quiet, Alarming Scientists (Thomas, 9/13).

NPR: A COVID-19 Vaccine May Be Only 50% Effective. Is That Good Enough? (Aubrey, 9/12).

NPR: Army Marshals Resources To Aid In Race For Coronavirus Vaccine (Bowman/Peñaloza, 9/14).

POLITICO: Trump officials rush to introduce new, untested vaccine tracking system (Tahir/Roubein, 9/13).

Reuters: Taiwan says plans to sign up for ‘COVAX’ vaccine allocation scheme (Blanchard, 9/12).

Reuters: WHO head urges rich nations to join vaccine scheme by Friday deadline (Miller, 9/14).

STAT: Pfizer and BioNTech announce plan to expand Covid-19 vaccine trial (Herper, 9/12).

STAT: The ethics of pausing a vaccine trial in the midst of a pandemic: a conversation with Ruth Faden (Skerrett, 9/11).

VOA News: The Price of Beijing’s Vaccine Diplomacy in Southeast Asia (Yang et al., 9/12).

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.